Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine. The move marks a major milestone in Genomate Health’s global expansion and establishes a strong operational base in Europe.
Post Views: 27



